Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

A novel human 3D lung microtissue model for nanoparticle-induced cell-matrix alterations.

Kabadi PK, Rodd AL, Simmons AE, Messier NJ, Hurt RH, Kane AB.

Part Fibre Toxicol. 2019 Apr 3;16(1):15. doi: 10.1186/s12989-019-0298-0.

2.

A 3D fish liver model for aquatic toxicology: Morphological changes and Cyp1a induction in PLHC-1 microtissues after repeated benzo(a)pyrene exposures.

Rodd AL, Messier NJ, Vaslet CA, Kane AB.

Aquat Toxicol. 2017 May;186:134-144. doi: 10.1016/j.aquatox.2017.02.018. Epub 2017 Feb 21.

3.

Inhibition of Helicobacter pylori Glu-tRNAGln amidotransferase by novel analogues of the putative transamidation intermediate.

Pham VH, Maaroufi H, Balg C, Blais SP, Messier N, Roy PH, Otis F, Voyer N, Lapointe J, Chênevert R.

FEBS Lett. 2016 Oct;590(19):3335-3345. doi: 10.1002/1873-3468.12380. Epub 2016 Sep 25.

4.

Hypothalamic Sirt1 regulates food intake in a rodent model system.

Cakir I, Perello M, Lansari O, Messier NJ, Vaslet CA, Nillni EA.

PLoS One. 2009 Dec 15;4(12):e8322. doi: 10.1371/journal.pone.0008322.

5.

Quality assessment of neoadjuvant therapy use in breast conservation: barriers to implementation.

James T, McCahill L, Ratliff J, Ashikaga T, Single R, Sheehey-Jones J, Messier N, Stanley M, Krag D, Harlow S.

Breast J. 2009 Sep-Oct;15(5):524-6. doi: 10.1111/j.1524-4741.2009.00771.x. Epub 2009 Jul 31.

PMID:
19624412
6.

Intracellular survival of Leishmania species that cause visceral leishmaniasis is significantly reduced by HIV-1 protease inhibitors.

Trudel N, Garg R, Messier N, Sundar S, Ouellette M, Tremblay MJ.

J Infect Dis. 2008 Nov 1;198(9):1292-9. doi: 10.1086/592280.

PMID:
18816190
7.

Genome-wide gene expression profiling analysis of Leishmania major and Leishmania infantum developmental stages reveals substantial differences between the two species.

Rochette A, Raymond F, Ubeda JM, Smith M, Messier N, Boisvert S, Rigault P, Corbeil J, Ouellette M, Papadopoulou B.

BMC Genomics. 2008 May 29;9:255. doi: 10.1186/1471-2164-9-255.

8.

A protein of the leucine-rich repeats (LRRs) superfamily is implicated in antimony resistance in Leishmania infantum amastigotes.

Genest PA, Haimeur A, Légaré D, Sereno D, Roy G, Messier N, Papadopoulou B, Ouellette M.

Mol Biochem Parasitol. 2008 Mar;158(1):95-9. doi: 10.1016/j.molbiopara.2007.11.008. Epub 2007 Nov 22.

PMID:
18164495
9.

Modulation of gene expression in human macrophages treated with the anti-leishmania pentavalent antimonial drug sodium stibogluconate.

El Fadili K, Imbeault M, Messier N, Roy G, Gourbal B, Bergeron M, Tremblay MJ, Légaré D, Ouellette M.

Antimicrob Agents Chemother. 2008 Feb;52(2):526-33. Epub 2007 Dec 10.

10.

Role of the ABC transporter PRP1 (ABCC7) in pentamidine resistance in Leishmania amastigotes.

Coelho AC, Messier N, Ouellette M, Cotrim PC.

Antimicrob Agents Chemother. 2007 Aug;51(8):3030-2. Epub 2007 Apr 23.

11.
12.

Lack of self-renewal capacity in Fancc-/- stem cells after ex vivo expansion.

Habi O, Delisle MC, Messier N, Carreau M.

Stem Cells. 2005 Sep;23(8):1135-41. Epub 2005 Jul 14.

13.

Role of the ABC transporter MRPA (PGPA) in antimony resistance in Leishmania infantum axenic and intracellular amastigotes.

El Fadili K, Messier N, Leprohon P, Roy G, Guimond C, Trudel N, Saravia NG, Papadopoulou B, Légaré D, Ouellette M.

Antimicrob Agents Chemother. 2005 May;49(5):1988-93.

14.

Leishmania major LmACR2 is a pentavalent antimony reductase that confers sensitivity to the drug pentostam.

Zhou Y, Messier N, Ouellette M, Rosen BP, Mukhopadhyay R.

J Biol Chem. 2004 Sep 3;279(36):37445-51. Epub 2004 Jun 25.

15.

Modulation of gene expression in Leishmania drug resistant mutants as determined by targeted DNA microarrays.

Guimond C, Trudel N, Brochu C, Marquis N, El Fadili A, Peytavi R, Briand G, Richard D, Messier N, Papadopoulou B, Corbeil J, Bergeron MG, Légaré D, Ouellette M.

Nucleic Acids Res. 2003 Oct 15;31(20):5886-96.

16.

Antimony uptake systems in the protozoan parasite Leishmania and accumulation differences in antimony-resistant parasites.

Brochu C, Wang J, Roy G, Messier N, Wang XY, Saravia NG, Ouellette M.

Antimicrob Agents Chemother. 2003 Oct;47(10):3073-9.

17.

Proteome mapping of the protozoan parasite Leishmania and application to the study of drug targets and resistance mechanisms.

Drummelsmith J, Brochu V, Girard I, Messier N, Ouellette M.

Mol Cell Proteomics. 2003 Mar;2(3):146-55. Epub 2003 Mar 15.

18.

RXR acts as a coregulator in the regulation of genes of the hypothalamo-pituitary axis by thyroid hormone receptors.

Laflamme L, Hamann G, Messier N, Maltais S, M-F Langlois.

J Mol Endocrinol. 2002 Aug;29(1):61-72.

PMID:
12200229
19.

Accelerated progression of asbestos-induced mesotheliomas in heterozygous p53+/- mice.

Vaslet CA, Messier NJ, Kane AB.

Toxicol Sci. 2002 Aug;68(2):331-8.

PMID:
12151629
20.
21.

In vitro effect of Triac on resistance to thyroid hormone receptor mutants: potential basis for therapy.

Messier N, Laflamme L, Hamann G, Langlois MF.

Mol Cell Endocrinol. 2001 Mar 28;174(1-2):59-69.

PMID:
11306172
22.

Triac regulation of transcription is T(3) receptor isoform- and response element-specific.

Messier N, Langlois MF.

Mol Cell Endocrinol. 2000 Jul 25;165(1-2):57-66.

PMID:
10940484
23.
24.

Growth factor responses and protooncogene expression of murine mesothelial cell lines derived from asbestos-induced mesotheliomas.

Goodglick LA, Vaslet CA, Messier NJ, Kane AB.

Toxicol Pathol. 1997 Nov-Dec;25(6):565-73.

PMID:
9437800
25.
26.

Functional expression and site-directed mutagenesis of a synthetic gene for alpha-bungarotoxin.

Rosenthal JA, Hsu SH, Schneider D, Gentile LN, Messier NJ, Vaslet CA, Hawrot E.

J Biol Chem. 1994 Apr 15;269(15):11178-85.

27.

Treatment of schistosomiasis by purine nucleoside analogues in combination with nucleoside transport inhibitors.

el Kouni MH, Messier NJ, Cha S.

Biochem Pharmacol. 1987 Nov 15;36(22):3815-21.

PMID:
3689423

Supplemental Content

Loading ...
Support Center